These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 15001115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T.
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B.
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [Abstract] [Full Text] [Related]

  • 6. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B.
    Eur J Respir Dis Suppl; 1987 Mar; 153():242-8. PubMed ID: 3322864
    [Abstract] [Full Text] [Related]

  • 7. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS, Wallander KA.
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK, Sinha SK.
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
    Vento G, Tana M, Tirone C, Aurilia C, Lio A, Perelli S, Ricci C, Romagnoli C.
    Acta Biomed; 2012 Oct; 83 Suppl 1():33-6. PubMed ID: 23029875
    [Abstract] [Full Text] [Related]

  • 12. Overview of surfactant replacement trials.
    Suresh GK, Soll RF.
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [Abstract] [Full Text] [Related]

  • 13. Repeat surfactant therapy for postsurfactant slump.
    Katz LA, Klein JM.
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK.
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [Abstract] [Full Text] [Related]

  • 15. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
    Sinha S, Moya F, Donn SM.
    Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
    [Abstract] [Full Text] [Related]

  • 16. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome.
    Bae YM, Bae CW, Oh MH, Lee SH, Woo KM, Jung KB.
    J Perinat Med; 2009 Apr; 37(5):561-4. PubMed ID: 19492923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inherited disorders of neonatal lung diseases.
    Yurdakök M.
    Turk J Pediatr; 2004 Apr; 46(2):105-14. PubMed ID: 15214737
    [Abstract] [Full Text] [Related]

  • 19. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B.
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [Abstract] [Full Text] [Related]

  • 20. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants.
    Curstedt T, Johansson J.
    Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.